A Randomized, Placebo-controlled, Parallel Group Multiple Dose Study of Rhinocort Aqua (budesonide) Nasal Spray on the Hypothalamic-Pituitary-Adrenal (HPA) Axis Function in Pediatric Patients with Allergic Rhinitis

Study identifier:SD-005-0697

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Randomized, Placebo-controlled, Parallel Group Multiple Dose Study of Rhinocort Aqua (budesonide) Nasal Spray on the Hypothalamic-Pituitary-Adrenal (HPA) Axis Function in Pediatric Patients with Allergic Rhinitis

Medical condition

Allergic Rhinitis

Phase

Phase 3

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Jan 2001
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria